TY - JOUR A1 - Ana I., González-González A1 - Dinh, Truc Sophia A1 - Brünn, Robin A1 - Brückle, Janina Maria-Sophie A1 - Schwarz, Christine A1 - Dieckelmann, Mirjam A1 - Müller, Beate A1 - Akker, Marjan van den T1 - Multimorbidity in middle-aged persons: experiences of patients and their health care providers: Protocol of a qualitative stakeholder analysis T2 - F1000Research N2 - Middle-aged persons with multimorbidity have to take their illnesses into account in their daily work, family and leisure activities. The MuMiA project aims to identify early preventive measures that make it easier for those between 30 and 60 years of age with multiple chronic diseases to manage their illnesses in their everyday lives. An interdisciplinary workshop and interviews with multimorbid middle-aged adults and their principal healthcare providers will be used to collect information on the management of care in the contexts of patients’ daily work, family and leisure activities. Data obtained in the interviews will be coded inductively and analysed using content analysis. Workshop outputs will be transcribed and evaluated by the authors. This study has received ethical approval from the Faculty of Medicine Ethics Committee of Goethe University (2021-47). The project will generate prevention recommendations that reflect the experiences of middle-aged persons living with multimorbidity and the views of their principal healthcare providers. The findings will be disseminated via conferences and peer-reviewed publications. KW - Multimorbidity KW - middle-aged KW - everyday life KW - qualitative research Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/75195 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-751953 SN - 2046-1402 N1 - Gefördert durch den Open-Access-Publikationsfonds der Goethe-Universität N1 - Extended data Open Science Framework: Multimorbidity in middle-aged persons: experiences of patients and their health care providers, https://doi.org/10.17605/OSF.IO/M8X69 VL - 11 IS - art. 655 SP - 1 EP - 7 PB - London CY - F1000 Research Ltd ER -